| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 12/22/2004 | CN1181207C Cell culture process of producing Xinjiang Saussurea involucrate general flavone |
| 12/22/2004 | CN1181201C LAG-3 splice variants |
| 12/22/2004 | CN1181195C Culturing method of human peripheral blood vessel endothelial ancestry cell |
| 12/22/2004 | CN1181194C Method of promoting haematococcus pluvialis growing multiplication and regulating astaxanthin synthesis and accumulation by photobiological reactor |
| 12/22/2004 | CN1181193C Method of regulating haematococcus pulvialis population density and synthesizing and accumulating astaxanthin by photoreactor |
| 12/22/2004 | CN1181098C Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan |
| 12/21/2004 | US6833493 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing |
| 12/21/2004 | US6833490 Involves decreasing the intracellular availability of trehalose-6-phosphate by plant cell transformation with a gene encoding trehalose-6-phosphate phosphatase from E. coli |
| 12/21/2004 | US6833446 Plant polynucleotide sequences encoding transcription factors that are components of the cellular transcription apparatus and the use of such polynucleotide sequences in the modification of gene expression |
| 12/21/2004 | US6833441 Compositions and methods for generating chimeric heteromultimers |
| 12/21/2004 | US6833437 Complement receptor type 1 (CR1)-like sequences |
| 12/21/2004 | US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity |
| 12/21/2004 | US6833271 Serum-free cell culture media |
| 12/21/2004 | US6833269 Stem cell culture product |
| 12/21/2004 | US6833268 Produced in response to immunization with any desired antigen |
| 12/21/2004 | US6833252 A DNA sequence that can be incorporated in cloning and expression vectors, transformed cell lines and transgenic animals; the vectors are useful in gene mapping and site-directed insertion of genes |
| 12/21/2004 | US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity |
| 12/21/2004 | CA2386066C Detection of hla-g |
| 12/16/2004 | WO2004108945A2 Oligonucleotide modulation of cell adhesion |
| 12/16/2004 | WO2004108936A1 Flavivirus replicon packaging system |
| 12/16/2004 | WO2004108930A1 Genes participating in fgf signal transduction |
| 12/16/2004 | WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 12/16/2004 | WO2004108921A1 Method of nucleic acid infusion |
| 12/16/2004 | WO2004108910A1 Selection and propagation of progenitor cells |
| 12/16/2004 | WO2004108909A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| 12/16/2004 | WO2004108908A1 Neural crest stem cells and uses thereof |
| 12/16/2004 | WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell |
| 12/16/2004 | WO2004108893A2 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| 12/16/2004 | WO2004108888A2 Micropositioning cells for tissue engineering |
| 12/16/2004 | WO2004108882A2 Neural stem cells and methods of generating and utilizing same |
| 12/16/2004 | WO2004108840A2 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 12/16/2004 | WO2004108766A2 Anti-hgf-r antibodies and their use |
| 12/16/2004 | WO2004108208A2 Methods and apparatus for conversion of eukaryotic cells by application of electric and magnetic fields |
| 12/16/2004 | WO2004108166A1 Epas1 gene transfer to improve cell therapy |
| 12/16/2004 | WO2004108155A1 Cells used as carriers for bacteria |
| 12/16/2004 | WO2004108145A1 Therapeutical composition containing dentritic cells and use thereof |
| 12/16/2004 | WO2004108066A2 Neuronal regeneration and compound administration methods |
| 12/16/2004 | WO2004108011A1 Integrated microfluidic sperm isolation and insemination device |
| 12/16/2004 | WO2004094588A3 Postnatal stem cells and uses thereof |
| 12/16/2004 | WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift |
| 12/16/2004 | WO2004075861A3 Recombinant adeno-associated virus production |
| 12/16/2004 | WO2004071545A3 Compositions for neuronal tissue regeneration |
| 12/16/2004 | WO2004062602A3 Compositions and methods for targeted biological delivery of molecular carriers |
| 12/16/2004 | WO2004048527A3 Cells resistant to chemotherapeutic compounds and uses thereof |
| 12/16/2004 | WO2004033622A9 Preservation of rna and morphology in cells and tissues |
| 12/16/2004 | WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 12/16/2004 | WO2004022696A3 Fibrin cell supports and methods of use thereof |
| 12/16/2004 | WO2003090514A8 Adipocyte complement related protein zacrp14 |
| 12/16/2004 | WO2003087115B1 Oligomeric compounds having modified phosphate groups |
| 12/16/2004 | WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency |
| 12/16/2004 | WO2003057833A3 Mutant chromophores/fluorophores and methods for making and using the same |
| 12/16/2004 | WO2003054184A9 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 12/16/2004 | WO2003027254A3 15625 receptor, a novel g-protein coupled receptor |
| 12/16/2004 | WO2003005953A3 Viral proteins capable of binding lar |
| 12/16/2004 | WO2002095306A9 Cryopreservation system with controlled dendritic freezing front velocity |
| 12/16/2004 | US20040255353 Inbred corn line W69079 |
| 12/16/2004 | US20040255352 Transgenic seeds for propagation of male sterile disease, insect, drought, hebicide and heat resistant plants with enhanced carbohydrate and fatty acid metabolism; improving nutrient quality of crop plants |
| 12/16/2004 | US20040255349 Plant flower type targeting mads box gene |
| 12/16/2004 | US20040255343 Caspase-9 deficient animals and the use thereof |
| 12/16/2004 | US20040254363 Genes and snps associated with eating disorders |
| 12/16/2004 | US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254346 Human survivin interacting protein 1 (sip-1) |
| 12/16/2004 | US20040254342 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors |
| 12/16/2004 | US20040254105 recombinant vectors and recombinant host cells |
| 12/16/2004 | US20040253727 Using both insertional and physiochemical means to generate stable, genetic rearrangement in cells; tissue engineering |
| 12/16/2004 | US20040253725 Control of arthropod vectors of parasitic diseases |
| 12/16/2004 | US20040253724 Microorganism and production of carotinoid compounds thereby |
| 12/16/2004 | US20040253722 Process for the maturation of dentritic cells and a vaccine |
| 12/16/2004 | US20040253721 Methods of derivation and propagation of undifferentiated human embryonic stem (HES) cells on feeder-free matrices and human feeder layers |
| 12/16/2004 | US20040253720 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 12/16/2004 | US20040253719 Identification and Isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain |
| 12/16/2004 | US20040253718 Methods of producing neurons |
| 12/16/2004 | US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases |
| 12/16/2004 | US20040253706 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression |
| 12/16/2004 | US20040253695 Using enone reductase to generate optically active intermediates for use in the synthesis of pharmaceuticals |
| 12/16/2004 | US20040253686 Novel human kunitz-type inhibitors and methods relating thereto |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253681 Mitogenic oxygenase regulators |
| 12/16/2004 | US20040253675 Method for GPCR assay with a coexpressed Galpha protein |
| 12/16/2004 | US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
| 12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/16/2004 | US20040253655 Immunoassay for use in detection high blood pressure; immunodiagnostics |
| 12/16/2004 | US20040253653 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253599 Novel protein, its dna and use thereof |
| 12/16/2004 | US20040253591 Compositions and methods for making mutations in cell lines and animals |
| 12/16/2004 | US20040253590 Compositions and methods for making mutations in cell lines and animals |
| 12/16/2004 | US20040253589 Compositions and methods for making mutations in cell lines and animals |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253579 Natural killer cell line for use as tool in elucidation of mechanism of oncogenesis; identifying modulator for treatment of cell proliferative disorders |
| 12/16/2004 | US20040253574 Method for producing ready to use, antigen loaded or unloaded, cryconserved mature dendritic cells |
| 12/16/2004 | US20040253293 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 12/16/2004 | US20040253270 Nucleic acid encoding infectious, nonpathogenic porcine circovirus type-1(PCV1), which contains immunogenic open reading frame gene of pathogenic PCV2 in place of an ORF gene of PCV1 nucleic acid molecule; means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 12/16/2004 | US20040253269 Use of dictyotal extracts in the production of a topical composition |
| 12/16/2004 | US20040253250 Compositions and methods for regulating lymphocyte activation |